Clever Instruments S.L. Report issue

For profit Phase 4
Founded: Barcelona Spain (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2014
NCT02248948
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Clever Instruments S.L.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Candidiasis (Phase 4)

Hyperkinesis (Phase 4)

Vaginal Diseases (Phase 4)

Vaginosis, Bacterial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 6